Diagnosed with endometriosis after years of debilitating symptoms, April Christina shares her experience with treatment, multidisciplinary care, and the emotional toll of infertility.

Stephanie Pearson, MD, FACOG, shares her journey working in obstetrics and gynecology; plus, how one event changed her entire life.

Pregnancy may lower Long COVID risk, with researchers linking immune changes to reduced symptoms, though some groups remain vulnerable.

A new study highlights the benefits of doula care, showing increased vaginal birth after cesarean rates, reduced preterm births, and improved postpartum care among diverse patient populations.

A new study reveals that consuming high-glycemic foods during the third trimester of pregnancy may impact infant temperament and emotional health.

Experts release first clinical guidance on polygenic risk scores for breast cancer, outlining integration into screening and prevention strategies.

A new study reported how a soluble fms-like tyrosine kinase-1 to placental growth factor ratio can help predict preeclampsia progression, aiding in risk assessment and optimizing patient care.

Panelists discuss how developing an effective pain management plan for intrauterine device (IUD) insertion requires patient cooperation, thorough medical history review, comprehensive education about procedures and tools, consideration of individualized needs, planning for interventions like sedation or antianxiety medication (which may not always be available), and implementation of trauma-informed care principles to ensure true informed consent and patient autonomy.

A recent study highlights the heightened risk of perinatal mortality in pregnancies affected by type 2 diabetes, emphasizing the need for improved prenatal care and risk management.

Giovanni Traverso, PhD, reveals the benefits of an innovative small-needle contraceptive implant that enhances accessibility, minimizes discomfort, and offers a versatile platform for long-acting drug delivery.

A new study from Intermountain Health reveals that while disparities in heart disease outcomes between men and women are shrinking, women still face unique risks and challenges in diagnosis and treatment.

Check out the top conferences happening in the second quarter of 2025.

Read our latest Letter to the Editor, focusing on health plans and the ACA contraceptive requirements.

The FDA has approved Visby Medical’s at-home sexually transmitted infection test, allowing women to screen for chlamydia, gonorrhea, and trichomoniasis without a prescription.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

The 2025 Canadian Postpartum Guidelines recommend at least 120 minutes of weekly exercise, daily pelvic floor training, and improved sleep hygiene to enhance maternal and infant health.

A new study found that open-label placebos can effectively reduce the intensity and interference of premenstrual syndrome symptoms, even when patients know they are taking a placebo.

The study is among the first to examine dietary patterns relating to overall healthy aging rather than specific diseases or mortality.

A new study suggests that sex-based differences in the kynurenine pathway may contribute to depression risk in adolescents, offering insights for personalized treatment approaches.

A new study found that exclusive or longer-duration breastfeeding is associated with a reduced risk of language, social, and neurodevelopmental delays in young children.

The approval marks a vital step toward care for urinary tract infections, helping to reduce recurrence and improve patients’ quality of life.

Ryan Haumschild, PharmD, MS, MBA, CPEL, explains the impact recently FDA-approved gepotidacin will have on uncomplicated UTIs and what this means in terms of antibiotic stewardship.

A new study highlights the importance of analyzing racial and ethnic subgroups to better understand prenatal depression diagnoses, symptom severity, and disparities in treatment.

A recent study identified key outcomes for vasa previa diagnosis and treatment, uniting patient experiences and clinical expertise to improve future research and guidelines.

Panelists discuss how physicians should empower and educate patients about intrauterine devices (IUDs) by addressing concerns directly rather than downplaying them, acknowledging pain as a legitimate issue while presenting all available options, and recognizing that IUDs are not appropriate for everyone. No patient should feel pressured to choose this method.